Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Elzsa vs Diane-35 in Healthy Females
NCT04964193Phase 1Completed
- Sponsor
- Sydna Farma
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of cyproterone and ethinyl estradiol in acne vulgaris and hirsutism (2 arms), sponsored by Sydna Farma. Primary endpoints: Area Under the Plasma Concentration-Time Curve at 72 hours and Maximum Plasma Concentration at 72 hours. Started Mar 2019; status: completed.
02
Drugs
cyproteroneethinyl estradiol
03
Conditions
acne vulgarishirsutism
Beyond the preview
Go deeper on NCT04964193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964193.